nodes	percent_of_prediction	percent_of_DWPC	metapath
Tocainide—CYP1A2—urine—polycystic ovary syndrome	0.0231	0.0857	CbGeAlD
Tocainide—SCN7A—adipose tissue—polycystic ovary syndrome	0.0173	0.0641	CbGeAlD
Tocainide—SCN7A—adrenal gland—polycystic ovary syndrome	0.0155	0.0575	CbGeAlD
Tocainide—SCN7A—female gonad—polycystic ovary syndrome	0.0144	0.0536	CbGeAlD
Tocainide—SCN9A—pituitary gland—polycystic ovary syndrome	0.0136	0.0504	CbGeAlD
Tocainide—SCN9A—adipose tissue—polycystic ovary syndrome	0.0135	0.0502	CbGeAlD
Tocainide—SCN7A—endocrine gland—polycystic ovary syndrome	0.0134	0.0498	CbGeAlD
Tocainide—SCN9A—adrenal gland—polycystic ovary syndrome	0.0121	0.045	CbGeAlD
Tocainide—SCN4A—pituitary gland—polycystic ovary syndrome	0.0121	0.0449	CbGeAlD
Tocainide—SCN4A—adipose tissue—polycystic ovary syndrome	0.0121	0.0448	CbGeAlD
Tocainide—SCN8A—endocrine gland—polycystic ovary syndrome	0.012	0.0444	CbGeAlD
Tocainide—SCN4A—adrenal gland—polycystic ovary syndrome	0.0108	0.0402	CbGeAlD
Tocainide—SCN2A—pituitary gland—polycystic ovary syndrome	0.0107	0.0398	CbGeAlD
Tocainide—SCN10A—pituitary gland—polycystic ovary syndrome	0.0103	0.0384	CbGeAlD
Tocainide—SCN3A—pituitary gland—polycystic ovary syndrome	0.00942	0.035	CbGeAlD
Tocainide—SCN3A—adipose tissue—polycystic ovary syndrome	0.00938	0.0348	CbGeAlD
Tocainide—SCN2A—vagina—polycystic ovary syndrome	0.00887	0.0329	CbGeAlD
Tocainide—SCN3A—adrenal gland—polycystic ovary syndrome	0.00841	0.0312	CbGeAlD
Tocainide—SCN2A—endocrine gland—polycystic ovary syndrome	0.0083	0.0308	CbGeAlD
Tocainide—SCN10A—endocrine gland—polycystic ovary syndrome	0.008	0.0297	CbGeAlD
Tocainide—SCN3A—vagina—polycystic ovary syndrome	0.0078	0.0289	CbGeAlD
Tocainide—SCN5A—vagina—polycystic ovary syndrome	0.00777	0.0289	CbGeAlD
Tocainide—ALB—adrenal gland—polycystic ovary syndrome	0.00671	0.0249	CbGeAlD
Tocainide—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00383	0.0142	CbGeAlD
Tocainide—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000817	0.00112	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—LEP—polycystic ovary syndrome	0.000807	0.0011	CbGpPWpGaD
Tocainide—ALB—Vitamin B12 Metabolism—INS—polycystic ovary syndrome	0.000805	0.0011	CbGpPWpGaD
Tocainide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000794	0.00109	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000793	0.00109	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—CRP—polycystic ovary syndrome	0.000784	0.00107	CbGpPWpGaD
Tocainide—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000772	0.00106	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000768	0.00105	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000758	0.00104	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—INS—polycystic ovary syndrome	0.000753	0.00103	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000748	0.00102	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000742	0.00102	CbGpPWpGaD
Tocainide—ALB—Vitamin B12 Metabolism—SERPINE1—polycystic ovary syndrome	0.00074	0.00101	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000729	0.000997	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000729	0.000997	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000728	0.000997	CbGpPWpGaD
Tocainide—ALB—Hemostasis—GP1BB—polycystic ovary syndrome	0.000712	0.000975	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000703	0.000962	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000703	0.000962	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000703	0.000962	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—INS—polycystic ovary syndrome	0.000689	0.000943	CbGpPWpGaD
Tocainide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000671	0.000918	CbGpPWpGaD
Tocainide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000667	0.000913	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000667	0.000913	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000666	0.000912	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—DLG4—polycystic ovary syndrome	0.000659	0.000902	CbGpPWpGaD
Tocainide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000658	0.000901	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—INS—polycystic ovary syndrome	0.000655	0.000897	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.000655	0.000896	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000654	0.000895	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—LEP—polycystic ovary syndrome	0.000652	0.000893	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—LEP—polycystic ovary syndrome	0.000624	0.000854	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.000623	0.000852	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000618	0.000846	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000617	0.000844	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—VEGFA—polycystic ovary syndrome	0.00061	0.000835	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—SERPINE1—polycystic ovary syndrome	0.000602	0.000824	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—LEP—polycystic ovary syndrome	0.000599	0.000821	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—LEP—polycystic ovary syndrome	0.000599	0.000821	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000587	0.000803	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000587	0.000803	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000586	0.000802	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—LEP—polycystic ovary syndrome	0.000578	0.000791	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—LEP—polycystic ovary syndrome	0.000578	0.000791	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000568	0.000778	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000558	0.000763	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—INS—polycystic ovary syndrome	0.000557	0.000763	CbGpPWpGaD
Tocainide—SCN5A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000552	0.000755	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000547	0.000749	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000543	0.000744	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—IGF1—polycystic ovary syndrome	0.000543	0.000744	CbGpPWpGaD
Tocainide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000541	0.00074	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000539	0.000738	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000539	0.000737	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000534	0.000731	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—INS—polycystic ovary syndrome	0.000533	0.00073	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000522	0.000715	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000522	0.000715	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000521	0.000713	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000519	0.00071	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—polycystic ovary syndrome	0.000518	0.000709	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—IL6—polycystic ovary syndrome	0.000518	0.000708	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—SERPINE1—polycystic ovary syndrome	0.000516	0.000706	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000515	0.000705	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—INS—polycystic ovary syndrome	0.000512	0.000701	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—INS—polycystic ovary syndrome	0.000512	0.000701	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000504	0.000689	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000504	0.000689	CbGpPWpGaD
Tocainide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000497	0.000681	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000495	0.000678	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000495	0.000678	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000494	0.000676	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—INS—polycystic ovary syndrome	0.000494	0.000676	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—INS—polycystic ovary syndrome	0.000494	0.000676	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000493	0.000675	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—polycystic ovary syndrome	0.000492	0.000673	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000492	0.000673	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000484	0.000663	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000478	0.000654	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PDE3B—polycystic ovary syndrome	0.000478	0.000654	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000478	0.000654	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000477	0.000653	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000477	0.000653	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000476	0.000651	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000472	0.000646	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000466	0.000638	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—IL6—polycystic ovary syndrome	0.000461	0.000631	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000453	0.000621	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000453	0.000621	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000451	0.000618	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00045	0.000616	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000445	0.000608	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000444	0.000608	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000437	0.000598	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000437	0.000598	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000435	0.000596	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—IL6—polycystic ovary syndrome	0.000422	0.000578	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00041	0.000562	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00041	0.000562	CbGpPWpGaD
Tocainide—ALB—Hemostasis—RACGAP1—polycystic ovary syndrome	0.000409	0.00056	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—LEP—polycystic ovary syndrome	0.000406	0.000556	CbGpPWpGaD
Tocainide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000403	0.000552	CbGpPWpGaD
Tocainide—ALB—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000389	0.000533	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000387	0.000529	CbGpPWpGaD
Tocainide—SCN5A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000381	0.000522	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000378	0.000517	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—IL6—polycystic ovary syndrome	0.000369	0.000506	CbGpPWpGaD
Tocainide—ALB—Metabolism—NMNAT3—polycystic ovary syndrome	0.000361	0.000495	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000356	0.000488	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—VEGFA—polycystic ovary syndrome	0.000355	0.000486	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000354	0.000484	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000352	0.000482	CbGpPWpGaD
Tocainide—ALB—Vitamin B12 Metabolism—IL6—polycystic ovary syndrome	0.000352	0.000482	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000352	0.000481	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—INS—polycystic ovary syndrome	0.000347	0.000475	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000345	0.000472	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000344	0.000471	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—IL6—polycystic ovary syndrome	0.000341	0.000467	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	0.000338	0.000463	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000337	0.000461	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000337	0.000461	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000336	0.000459	CbGpPWpGaD
Tocainide—ALB—Metabolism—LPCAT2—polycystic ovary syndrome	0.00033	0.000452	CbGpPWpGaD
Tocainide—ALB—Metabolism—SUOX—polycystic ovary syndrome	0.00033	0.000452	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—IL6—polycystic ovary syndrome	0.000329	0.000451	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—IL6—polycystic ovary syndrome	0.000326	0.000447	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000326	0.000447	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000326	0.000446	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000324	0.000443	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000324	0.000443	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—IL6—polycystic ovary syndrome	0.000314	0.000429	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—IL6—polycystic ovary syndrome	0.000314	0.000429	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000312	0.000427	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000312	0.000427	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000311	0.000426	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000307	0.000421	CbGpPWpGaD
Tocainide—ALB—Metabolism—ISYNA1—polycystic ovary syndrome	0.000307	0.00042	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—IL6—polycystic ovary syndrome	0.000302	0.000414	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—IL6—polycystic ovary syndrome	0.000302	0.000414	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—IL6—polycystic ovary syndrome	0.000301	0.000412	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.0003	0.000411	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000287	0.000393	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—IL6—polycystic ovary syndrome	0.000286	0.000392	CbGpPWpGaD
Tocainide—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000283	0.000388	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00028	0.000384	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000266	0.000364	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000264	0.000362	CbGpPWpGaD
Tocainide—ALB—Metabolism—TEAD2—polycystic ovary syndrome	0.000261	0.000358	CbGpPWpGaD
Tocainide—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	0.000261	0.000358	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000253	0.000346	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000251	0.000344	CbGpPWpGaD
Tocainide—ALB—Hemostasis—PLAT—polycystic ovary syndrome	0.00025	0.000342	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000247	0.000338	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—IL6—polycystic ovary syndrome	0.000244	0.000333	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000241	0.00033	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000241	0.00033	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000241	0.00033	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000236	0.000323	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—IL6—polycystic ovary syndrome	0.000233	0.000319	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000233	0.000319	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000231	0.000316	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000231	0.000316	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000229	0.000313	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000228	0.000312	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000227	0.000311	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—IL6—polycystic ovary syndrome	0.000224	0.000306	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—IL6—polycystic ovary syndrome	0.000224	0.000306	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000219	0.0003	CbGpPWpGaD
Tocainide—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	0.000219	0.0003	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000216	0.000296	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—IL6—polycystic ovary syndrome	0.000216	0.000295	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—IL6—polycystic ovary syndrome	0.000216	0.000295	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000215	0.000294	CbGpPWpGaD
Tocainide—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000214	0.000293	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	0.000213	0.000291	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00021	0.000287	CbGpPWpGaD
Tocainide—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	0.000208	0.000284	CbGpPWpGaD
Tocainide—ALB—Metabolism—STAR—polycystic ovary syndrome	0.000198	0.000271	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000198	0.000271	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000196	0.000268	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000196	0.000268	CbGpPWpGaD
Tocainide—ALB—Hemostasis—GNAS—polycystic ovary syndrome	0.000192	0.000263	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000186	0.000255	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000183	0.00025	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000183	0.00025	CbGpPWpGaD
Tocainide—ALB—Metabolism—HMMR—polycystic ovary syndrome	0.000176	0.000241	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000176	0.00024	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000173	0.000237	CbGpPWpGaD
Tocainide—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	0.000168	0.00023	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000166	0.000228	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000166	0.000227	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000158	0.000216	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000157	0.000215	CbGpPWpGaD
Tocainide—ALB—Metabolism—LHB—polycystic ovary syndrome	0.000153	0.00021	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000153	0.00021	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	0.000152	0.000208	CbGpPWpGaD
Tocainide—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	0.00015	0.000205	CbGpPWpGaD
Tocainide—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	0.000145	0.000199	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000145	0.000199	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000138	0.00019	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000137	0.000187	CbGpPWpGaD
Tocainide—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	0.000134	0.000183	CbGpPWpGaD
Tocainide—ALB—Metabolism—RRM2—polycystic ovary syndrome	0.00013	0.000177	CbGpPWpGaD
Tocainide—ALB—Metabolism—YAP1—polycystic ovary syndrome	0.000125	0.000171	CbGpPWpGaD
Tocainide—ALB—Hemostasis—IGF1—polycystic ovary syndrome	0.000124	0.00017	CbGpPWpGaD
Tocainide—ALB—Hemostasis—AKT2—polycystic ovary syndrome	0.000124	0.00017	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000123	0.000169	CbGpPWpGaD
Tocainide—ALB—Metabolism—NAMPT—polycystic ovary syndrome	0.00012	0.000164	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000119	0.000163	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	0.000118	0.000162	CbGpPWpGaD
Tocainide—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000118	0.000161	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000118	0.000161	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000118	0.000161	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000116	0.000159	CbGpPWpGaD
Tocainide—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	0.000112	0.000153	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00011	0.000151	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	0.00011	0.000151	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.000107	0.000147	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000105	0.000144	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000102	0.000139	CbGpPWpGaD
Tocainide—ALB—Metabolism—TH—polycystic ovary syndrome	9.53e-05	0.00013	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	9.35e-05	0.000128	CbGpPWpGaD
Tocainide—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	9.27e-05	0.000127	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	9.06e-05	0.000124	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	8.73e-05	0.00012	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	8.71e-05	0.000119	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	8.39e-05	0.000115	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.34e-05	0.000114	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	8.28e-05	0.000113	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.23e-05	0.000113	CbGpPWpGaD
Tocainide—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	8.12e-05	0.000111	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	7.82e-05	0.000107	CbGpPWpGaD
Tocainide—ALB—Metabolism—GNAS—polycystic ovary syndrome	7.78e-05	0.000106	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	7.7e-05	0.000105	CbGpPWpGaD
Tocainide—ALB—Metabolism—NCOR1—polycystic ovary syndrome	7.41e-05	0.000101	CbGpPWpGaD
Tocainide—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	7.02e-05	9.61e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—TH—polycystic ovary syndrome	6.66e-05	9.12e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—MTHFR—polycystic ovary syndrome	6.55e-05	8.96e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	6.48e-05	8.87e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	6.1e-05	8.34e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	5.44e-05	7.45e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—PPARG—polycystic ovary syndrome	5.31e-05	7.27e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—POMC—polycystic ovary syndrome	5.24e-05	7.17e-05	CbGpPWpGaD
Tocainide—ALB—Metabolism—INS—polycystic ovary syndrome	5.21e-05	7.13e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	5.18e-05	7.09e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	4.91e-05	6.72e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	4.58e-05	6.27e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	3.71e-05	5.08e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	3.66e-05	5.01e-05	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—INS—polycystic ovary syndrome	3.64e-05	4.99e-05	CbGpPWpGaD
